The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine capacity and medical resources are also threatened. Therefore, we aimed to evaluate different screening strategies to balance outbreak control and consumption of resources. A community network of 2000 people, considering the heterogeneities of household size and age structure, was generated to reflect real contact networks, and a stochastic individual-based dynamic model was used to simulate SARS-CoV-2 transmission and assess different whole-area nucleic acid screening strategies. We designed a total of 87 screening strategies with different sampling methods, frequencies of screening, and timings of screening. The performance of these strategies was comprehensively evaluated by comparing the cumulative
Share this article
Share this article
SEOUL, Korea, May 23, 2021 /PRNewswire/ Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year s European Congress of Clinical Microbiology, the ECCMID.
Seegene s Dr. Guy Willem Lee, Director of Marketing Strategy introduced the diagnostic system under the theme of SARS-CoV-2 and Variants Full Screening Solution using its latest COVID-19 variant diagnostic tests. The backdrop of Korea s outstanding control at the onset of the pandemic is because of the one-platform diagnostic system that enables mass testing, said Lee. He added that the system enabled the diagnostic process from sample collection through PCR testing all at once, helping local authorities to quickly control the pandemic.
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.